Clinical Trials Directory

Trials / Conditions / Steroid Refractory GVHD

Steroid Refractory GVHD

10 registered clinical trials studyying Steroid Refractory GVHD — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingSafety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refrac
NCT06343792
ReAlta Life Sciences, Inc.Phase 2
Active Not RecruitingMaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients
NCT04769895
MaaT PharmaPhase 3
UnknownProspective Interventional Study Exploring the Microbiota Recolonization in SR-GvHD Patients Receiving MaaT013
NCT05017688
MaaT PharmaN/A
UnknownEvaluation of EFficacy and SaFEty of Leukotac (Inolimomab) in Pediatric Patients With SR-aGvHD
NCT04289103
ElsaLys BiotechPhase 3
CompletedECP Combination Study
NCT05052385
European Society for Blood and Marrow Transplantation—
CompletedDecidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/
NCT04926194
University Health Network, TorontoPhase 2
TerminatedItacitinib and Tocilizumab for Steroid Refractory Acute Graft Versus Host Disease
NCT04070781
Columbia UniversityPhase 1
CompletedRuxolitinib as add-on Therapy in Steroid-refractory Graft-vs-host Disease
NCT05663827
Yi-Lun WangPhase 3
TerminatedInfliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease
NCT01485055
Nationwide Children's HospitalPhase 2
AvailableEarly Access Program With MaaT013 in Steroid-refractory Acute Gastrointestinal Graft Versus Host Disease
NCT04768907
MaaT Pharma—